📰 Psychedelics News
Curated updates on microdosing, research, policy, and community.
Filters
Global Altered States: CDMX Cannabis Clubs
This is the first entry in Global Altered States, a paid-only monthly series built around first-hand exposure.
Le gaz hilarant : Le protoxyde d’azote (N2O)
Un aperçu objectif du protoxyde d’azote, examinant sa normalisation croissante, ses effets puissants, son attrait, ses risques et son histoire. The post Le gaz hilarant : Le protoxyde d’azote (N2O) appeared first on C...
Legislative updates in Mississippi, West Virginia, Oregon, and New Hampshire; Fast-tracked federal approval of Compass's synthetic psilocybin was vetoed; Federal bill proposes VA study psychedelics
Plus: Definium (formerly MindMed) hit with “trade secret” lawsuit; and an analysis of ibogaine experiences
Why the Brain Keeps Inventing Entities
Welcome to the Psychedelic Blog. I write about the impact of Psychedelics on Grieving, Relationships, Culture & Death.
Veterans Caught Between Policy Paralysis and Controversy in DC
As Congress weighs new psychedelic bills, veterans remain caught between promise, policy, and unresolved ethical concerns. [...] Read More... The post Veterans Caught Between Policy Paralysis and Controversy in DC app...
Pα+ Psychedelic Bulletin #219: Trump Admin. Vetoed Compass Priority Voucher; Ibogaine in Focus; Definium Sued by Former Vendor; Psychedelics Feature in Epstein Files
Trump Administration Vetoed Compass Pathways Priority Voucher • Ibogaine in Focus (State Bills Progress, Safety and Regulation, State Programs and Global Supply, Drug Development Remains Early-Stage, DemeRx Shares P...
In a Defining Election Year, MAPS Releases Policy Guidebook to Shape the Future of Psychedelic Reform
Washington, DC; February 4, 2026 — With the United States in a pivotal election year, the Multidisciplinary Association for Psychedelic Studies (MAPS) released its Policy Guidebook, a robust resource for psychedelic p...
Center for MINDS: Bruce Damer on Why We Need Psychedelic-Catalysed Innovation
Psychedelic Alpha’s Charles Bliss speaks with astrobiologist Dr. Bruce Damer about the Center for MINDS' mission and how it is picking up the “abandoned thread” of research into psychedelics as catalysers of creativit...
Le LSA : la version naturelle du LSD ?
Nuit compare les expériences de LSA issues de deux sources de semences, contextualisées par l’histoire et la science, dans le but de présenter une vision équilibrée des effets variables, des incertitudes, des risques ...
APS Survey
· Help Us Grow Together The Australian Psychedelic Society (APS) is built on community connection, shared knowledge, and a strong commitment to harm reduction and safety. We want to make sure what we offer g...
Legislation, Industry, and the Future of Psilocybin for PTSD
The FDA acceptance of Compass Pathway’s Investigational New Drug Application for their COMP360 compound as a possible therapy for PTSD introduces a new area of possible therapies using psilocybin. The post Legislati...
Neuroscientist Uses VR to Study Why Psychedelics Make Us Trip
Virtual reality offers a new lens on the science behind the psychedelic experience. [...] Read More... The post Neuroscientist Uses VR to Study Why Psychedelics Make Us Trip appeared first on DoubleBlind Mag.
Can Psychedelics Help Mend Broken and Ailing Brains?
Stroke, traumatic brain injury, and neurodegenerative diseases are leading, interconnected causes of global disability and economic burden with limited effective treatments. Sam Gandy highlights the potential of psych...
Patient Safety After a Death: What Transparency Can and Cannot Do
A Tragedy at an Ibogaine Clinic — and the Policy Failure Behind It A patient death in any care setting is a tragedy. In this case, it involves ibogaine, a medically complex intervention that sits outside regulated med...
The Psychedelic News Feed: January 26 – Febraury 1, 2026
Your one-stop digest for the latest coverage of psychedelics business, policy, research and beyond, for the week commencing January 26, 2026.